BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6879125)

  • 1. [Drug therapy in impaired liver and kidney function].
    Galeazzi RL
    Schweiz Med Wochenschr; 1983 May; 113(20):726-32. PubMed ID: 6879125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic bases of dosage adaptation of drugs in renal insufficiency].
    Lesne M
    J Pharm Belg; 1988; 43(3):212-32. PubMed ID: 3171871
    [No Abstract]   [Full Text] [Related]  

  • 3. [Safe drug prescribing for patients with renal failure].
    Tanaka A; Shimizu H; Matsuo S
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():58-66. PubMed ID: 18074518
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of estimated glomerular filtration rate with estimated creatinine clearance in the dosing of drugs requiring adjustments in elderly patients with declining renal function.
    Spruill WJ; Wade WE; Cobb HH
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):153-60. PubMed ID: 18775390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuing the use of the Cockcroft-Gault equation for drug dosing in patients with impaired renal function.
    Spruill WJ; Wade WE; Cobb HH
    Clin Pharmacol Ther; 2009 Nov; 86(5):468-70. PubMed ID: 19844221
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adjusting dosage of drugs in patients with kidney or liver failure].
    Krähenbühl S
    Schweiz Med Wochenschr; 1998 Feb; 128(6):189-94. PubMed ID: 9540139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function.
    Welink J; Boven E; Vermorken JB; Gall HE; van der Vijgh WJ
    Clin Cancer Res; 1999 Sep; 5(9):2349-58. PubMed ID: 10499604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient.
    Yogaratnam D; Miller MA; Smith BS
    Crit Care Nurs Clin North Am; 2005 Sep; 17(3):245-50. PubMed ID: 16115532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Unwanted and toxic drug effects].
    Dominok GW; Terhaag B
    Z Arztl Fortbild (Jena); 1984; 78(23):973-6. PubMed ID: 6528640
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug dosing guidelines in patients with renal failure.
    Swan SK; Bennett WM
    West J Med; 1992 Jun; 156(6):633-8. PubMed ID: 1615656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging evidence of the impact of kidney disease on drug metabolism and transport.
    Nolin TD; Naud J; Leblond FA; Pichette V
    Clin Pharmacol Ther; 2008 Jun; 83(6):898-903. PubMed ID: 18388866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current Swedish renal function tests must be better. Uncertain diagnosis with routine formulas--great risk of wrong drug dosages].
    Hansson LO; Wadström J; Lipcsey M; Biglarnia A; Larsson A
    Lakartidningen; 2008 Mar 5-11; 105(10):731-4. PubMed ID: 18422239
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of the MDRD study equation to estimate kidney function for drug dosing.
    Stevens LA; Levey AS
    Clin Pharmacol Ther; 2009 Nov; 86(5):465-7. PubMed ID: 19844220
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of kidney function and biopsy results in liver failure patients with renal dysfunction: a new look to combined liver kidney allocation in the post-MELD era.
    Tanriover B; Mejia A; Weinstein J; Foster SV; Ghalib R; Mubarak A; Cheng SS
    Transplantation; 2008 Dec; 86(11):1548-53. PubMed ID: 19077888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current state of knowledge on age, sex, and their interactions on clinical pharmacology.
    Schwartz JB
    Clin Pharmacol Ther; 2007 Jul; 82(1):87-96. PubMed ID: 17495875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dose adaptation of drugs for liver patients using a simple risk classification].
    Zysset T; Bircher J
    Internist (Berl); 1983 Mar; 24(3):151-61. PubMed ID: 6347941
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug dosage in patients with impaired renal function.
    Dettli L; Spring P; Habersang R
    Postgrad Med J; 1970 Oct; ():Suppl:32-5. PubMed ID: 5488205
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnostic and pathophysiological aspects of the determination of kidney function in animals].
    Reder S; Hartmann H
    Zentralbl Veterinarmed A; 1994 May; 41(4):253-67. PubMed ID: 7975970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of renal risk drugs in hospitalized patients with impaired renal function--an underestimated problem?
    Blix HS; Viktil KK; Moger TA; Reikvam A
    Nephrol Dial Transplant; 2006 Nov; 21(11):3164-71. PubMed ID: 16880181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal function and pharmacotherapy in children].
    Jovanović O
    Srp Arh Celok Lek; 1995 Jun; 123 Suppl 1():15-21. PubMed ID: 18193796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.